The 44% reduction in all-cause mortality observed among patients with obesity and co-occurring autoimmune disease is a striking finding that demands our attention, said Fatima Cody Stanford, MD, associate professor of medicine and pediatrics at Harvard Medical School, who was not involved in the study
That said, Wegovy is FDA-approved and widely prescribed for weight loss with excellent clinical responses, while retatrutide is still an investigational drug only available through clinical trials and its long-term safety and tolerability are still being studied
Semaglutide lengthens and steadies one of the guts hormonal notes, so the brain receives a clearer, sustained satiety signal rather than short, inconsistent pulses
Not Ideal For Daily Wellness Users Despite marketing claims, using Liquid I.V
Then, a few more patients